| Region reporting | African region | 222 (0.15) | 194 (8.41) |
| Region of the Americas | 28,277 (19.22) | 1,008 (43.71) |
| South-East Asia Region | 31 (0.02) | 17 (0.74) |
| European Region | 114,432 (77.76) | 1,015 (44.02) |
| Eastern mediterranean region | 69 (0.05) | 12 (0.52) |
| Western pacific region | 4,127 (2.80) | 60 (2.60) |
| Reporting year | 1969-1989 | 13 (0.01) | 6 (0.26) |
| 1990-1999 | 7 (0.00) | 4 (0.17) |
| 2000-2009 | 29 (0.02) | 13 (0.56) |
| 2010-2019 | 2,144 (1.46) | 201 (8.72) |
| 2020-2023 | 144,965 (98.51) | 2082 (90.29) |
| Reporter qualification | Health professional | 8,486 (5.77) | 422 (18.30) |
| Non-health professional | 109,575 (74.46) | 884 (38.33) |
| Unknown | 29,097 (19.77) | 1,000 (43.37) |
| Age, years | 0 to 11 | 181 (0.12) | 8 (0.35) |
| 12 to 17 | 4,274 (2.90) | 6 (0.26) |
| 18 to 44 | 104,724 (71.16) | 899 (38.99) |
| 719 (31.18) | 45 to 64 | 20,249 (13.76) | 157 (6.81) |
| ≥65 | 136 (0.09) | 517 (22.42) |
| Unknown | 17,594 (11.96) | 8 (0.35) |
| Delay (TTO), days | Median (Q1-Q3) | 1 (1-1) | 1 (1-1) |
| Drug class | Anthrax vaccines | 22 (0.01) | 36 (1.56) |
| Cholera vaccines | 1 (0.00) | 0 (0.00) |
| DTaP-IPV-Hib vaccines | 99 (0.07) | 41 (1.78) |
| Meningococcal vaccines | 57 (0.04) | 8 (0.35) |
| Pneumococcal vaccines | 8 (0.01) | 9 (0.39) |
| Tuberculosis vaccines | 1 (0.00) | 0 (0.00) |
| Typhoid vaccines | 21 (0.01) | 9 (0.39) |
| Encephalitis vaccines | 21 (0.01) | 8 (0.35) |
| Influenza vaccines | 148 (0.10) | 48 (2.08) |
| Hepatitis A vaccines | 70 (0.05) | 12 (0.52) |
| Hepatitis B vaccines | 80 (0.05) | 63 (2.73) |
| MMR vaccines | 32 (0.02) | 15 (0.65) |
| Rotavirus diarrhea vaccines | 0 (0.00) | 1 (0.04) |
| Varicella-zoster vaccines | 29 (0.02) | 9 (0.39) |
| Papillomavirus vaccines | 2,070 (1.41) | 3 (0.13) |
| COVID-19 mRNA vaccines | 129,010 (87.67) | 1,531 (66.39) |
| Ad5-vectored COVID-19 vaccines | 15,325 (10.41) | 471 (20.42) |
| Inactivated whole-virus COVID-19 vaccines | 94 (0.06) | 12 (0.52) |
| Others* | 70 (0.05) | 30 (1.3) |
| Fatal outcomes | Recovered/recovering | 104,200 (70.81) | 1,189 (51.56) |
| Fatal | 2 (0.00) | 0 (0.00) |
| Unknown | 42,956 (29.19) | 1,117 (48.44) |
| Single drug suspected | | 147,136 (99.99) | 2,306 (100.00) |